Human induced pluripotent stem cells technology in treatment resistant depression: novel strategies and opportunities to unravel ketamine’s fast-acting antidepressant mechanisms

Approximately 30% of Major Depressive Disorder (MDD) patients develop treatment-resistant depression (TRD). Among the different causes that make TRD so challenging in both clinical and research contexts, major roles are played by the inadequate understanding of MDD pathophysiology and the limitation...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ther Adv Psychopharmacol
Main Authors: Marcatili, Matteo, Sala, Carlo, Dakanalis, Antonios, Colmegna, Fabrizia, D’Agostino, Armando, Gambini, Orsola, Dell’Osso, Bernardo, Benatti, Beatrice, Conti, Luciano, Clerici, Massimo
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2020
Assuntos:
Novel Strategies for the Treatment of Depression
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7649879/
https://ncbi.nlm.nih.gov/pubmed/33224469
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2045125320968331
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados